Notice on soliciting public opinions on the registration template of production process information of listed drugs

Source: CDE 2016-12-26 in order to ensure the safety and effectiveness of public drug use, standardize and improve the management of drug production process, and make preparations for the registration and verification of production process information of listed drugs, our center has organized the drafting of the production process information registration template (Exposure Draft) of traditional Chinese Medicine, chemical drugs and biological products, and now we ask for opinions from the public If you have any comments, please send them to our center by email before January 23, 2017 Contact person: Jiang Yu; Hou Peng email: jiang@cde.org.cn; house@cde.org.cn Tel: 010-68921545; 010-68921520 Drug evaluation center of State Food and Drug Administration on December 23, 2016 Annex 1: Annex 1: registration template of production process information of traditional Chinese medicine (Draft for comments) Doc Annex 2: Annex 2: registration template of production process information of chemical drugs (Draft for comments) Doc Annex 3: Annex 3: registration template of production process information of biological products (Draft for comments) Doc